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Figure 1 MOG induced EAE follows a monophasic disease
course: Following immunisation, mice were scored daily.
Clinical scores expressed as an average ± S.E.M. EAE, n=6-39;
PBS, n=6-23. **P<0.005, ***P<0.001 versus PBS
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Figure 2 Serum expression of IL-22 correlates with EAE
disease progression: Serum expression of IL-22 was
determined by ELISA. EAE, n=6; PBS, n=5. **P<0.01,
***P<0.001 versus PBS, #P<0.05 versus EAE onset, ###P<0.001
versus EAE peak.
Figure 3 IL-22 expression in spinal correlates with EAE
disease progression: Spinal cord sections were stained for
expression of IL-22. Expression quantified using ImageJ. n=6
for all groups. **P<0.01, ***P<0.001 versus PBS control.
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Figure 4 IL-22 co-localises with neurons and astrocytes:
Double fluorescence staining was used to determine co-
localisation of IL-22 with neurons and astrocytes. Expression
quantified using ImageJ. n=6 for all groups. Scale bar= 100 ʅm.
***P <0.001 versus naïve.
Figure 5 IL-22 co-localises with several immune cells. Double
fluorescence staining was used to determine co-localisation of
IL-22 with various infiltrating immune cells. All sections used
were peak EAE. Expression quantified using ImageJ. n=5 for
each group. Scale bar= 50ʅm.
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Figure 6 IL-22R1 expression in spinal cord is elevated during
EAE within white matter and lesion areas: Spinal cord
sections were stained for expression of IL-22R1. Expression
quantified using ImageJ. n=6 for all groups. *P<0.05, **P<0.01,
***P<0.001 versus PBS control.
Figure 7 IL-22R1 co-localises with neurons and astrocytes:
Double fluorescence staining was used to determine co-
localisation of IL-22R1 with neurons and astrocytes. Expression
quantified using ImageJ. n=3 for all groups. Scale bar= 100 ʅm.
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 C57BL/6 female mice were
immunised subcutaneously with
MOG35-55 peptide or vehicle
emulsified in complete &ƌĞƵŶĚ Ɛ͛
adjuvant.
 Mice were weighed daily and
scored based on tail/leg paralysis.
Immunohistochemistry
 Immunohistochemistry was used to determine IL-22 (Abcam; ab18499) and IL-22R1 (R&D; 
MAB42941) expression and co-localisation with CNS resident cells and infiltrating immune 
cells.
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Our data shows that:
 Serum IL-22 elevated during EAE in a similar manner to MS patients during active disease.³
 IL-22 and IL-22R1 expression elevated in EAE spinal cord tissue, particularly within proximity of inflammatory lesions.
 Neurons express comparable levels of IL-22 and IL-22R1 in naïve and EAE mice however astrocytic expression of both is elevated during EAE specifically within the inflammatory
lesions.
 Our data suggests IL-22 plays an important role in the development and progression of CNS inflammation however whether this function is mediated through astrocytes or 
other means  has still to be determined.
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Background
Interleukin (IL)-22, a T-helper (Th)-17 linked cytokine, has been associated with
several autoimmune diseases. However, the role of IL-22 in multiple sclerosis
(MS) has still be elucidated¹.
While IL-22 is believed to aid in lymphocyte infiltration² of the CNS and elevated
levels were observed in serum and lesion of MS patients, studies have
highlighted potentially protective functions³ within MS and experimental
autoimmune encephalomyelitis (EAE) ʹ an animal model of MS.
Aim
This study aims to characterise the expression of IL-22 and its receptor subunit
IL-22R1 in normal and EAE CNS tissue, and examine any potential correlation
between expression level and disease severity.
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